. | Group A (N = 18) . | Group B (N = 19) . | P-value . |
---|---|---|---|
VAC therapy | 0 | 15 (79%) | – |
Mean VAC therapy (days) | – | 10 (±7) | – |
Wound closure post-SCF | 10 (±5) | 15 (±7) | 0.012 |
LOS in the hospital (days) | 22 (±12) | 26 (±14) | 0.34 |
Total antimicrobial therapy | 16 (±9) | 22 (±11) | 0.078 |
Recurrent SCF | 1 (6%) | 4 (21%) | 0.46 |
Follow-up (months) | 8 (±3) | 10 (±6) | – |
Overall mortality | 0 | 1 (5%) | 1.00 |
. | Group A (N = 18) . | Group B (N = 19) . | P-value . |
---|---|---|---|
VAC therapy | 0 | 15 (79%) | – |
Mean VAC therapy (days) | – | 10 (±7) | – |
Wound closure post-SCF | 10 (±5) | 15 (±7) | 0.012 |
LOS in the hospital (days) | 22 (±12) | 26 (±14) | 0.34 |
Total antimicrobial therapy | 16 (±9) | 22 (±11) | 0.078 |
Recurrent SCF | 1 (6%) | 4 (21%) | 0.46 |
Follow-up (months) | 8 (±3) | 10 (±6) | – |
Overall mortality | 0 | 1 (5%) | 1.00 |
Bold values indicates statistically significant.
VAC: vacuum assisted closure therapy; LOS: length of stay in hospital.
. | Group A (N = 18) . | Group B (N = 19) . | P-value . |
---|---|---|---|
VAC therapy | 0 | 15 (79%) | – |
Mean VAC therapy (days) | – | 10 (±7) | – |
Wound closure post-SCF | 10 (±5) | 15 (±7) | 0.012 |
LOS in the hospital (days) | 22 (±12) | 26 (±14) | 0.34 |
Total antimicrobial therapy | 16 (±9) | 22 (±11) | 0.078 |
Recurrent SCF | 1 (6%) | 4 (21%) | 0.46 |
Follow-up (months) | 8 (±3) | 10 (±6) | – |
Overall mortality | 0 | 1 (5%) | 1.00 |
. | Group A (N = 18) . | Group B (N = 19) . | P-value . |
---|---|---|---|
VAC therapy | 0 | 15 (79%) | – |
Mean VAC therapy (days) | – | 10 (±7) | – |
Wound closure post-SCF | 10 (±5) | 15 (±7) | 0.012 |
LOS in the hospital (days) | 22 (±12) | 26 (±14) | 0.34 |
Total antimicrobial therapy | 16 (±9) | 22 (±11) | 0.078 |
Recurrent SCF | 1 (6%) | 4 (21%) | 0.46 |
Follow-up (months) | 8 (±3) | 10 (±6) | – |
Overall mortality | 0 | 1 (5%) | 1.00 |
Bold values indicates statistically significant.
VAC: vacuum assisted closure therapy; LOS: length of stay in hospital.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.